ArticleMolecular cancer therapeutics2022

PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors.

Anish Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.